Kestra Medical Technologies, Ltd.
KMTS
Rank in Stocks
#6544
Kestra Medical Technologies, Ltd. operates at the intersection of wearable... Kestra Medical Technologies, Ltd. operates at the intersection of wearable medical technology and digital healthcare. Its core mission is to revolutionize patient outcomes in cardiovascular disease through intelligent, intuitive, and connected monitoring and therapeutic intervention solutions. The company's flagship offering is the Cardiac Recovery System (CRS) platform, which it develops and commercializes. This unified solution seamlessly integrates cardiac monitoring, therapeutic treatment, digital health capabilities, and patient support services. A central component of the CRS is the ASSURE WCD, a wearable cardioverter defibrillator specifically engineered to protect individuals at elevated risk of sudden cardiac arrest (SCA). Beyond its hardware, the CRS platform also encompasses a suite of integrated digital solutions and services. These are designed to foster enhanced engagement and oversight between patients and healthcare providers, ultimately striving for improved patient well-being. Founded in 2014, the company is headquartered in Kirkland, Washington.
Share Price
$28.62
Last synced: 2026-11-12
Market Cap
$1.68B
Change (1 day)
-9.52%
Change (1 year)
11.58%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Kestra Medical Technologies, Ltd. (KMTS)
Category
Healthcare
Operating Margin for Kestra Medical Technologies, Ltd. (KMTS)
Operating Margin as of November 2026 TTM: -134.48%
According to Kestra Medical Technologies, Ltd.'s latest financial reports, its current operating margin (TTM) is -134.48%. At the end of 2025 the company had an operating margin of -177.85%.
Operating Margin history for Kestra Medical Technologies, Ltd. from 2020 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -134.48% | -24.39% |
| 2025 | -177.85% | -41.85% |
| 2024 | -305.83% | -70.98% |
| 2023 | -1,054.01% | 0.00% |
| 2021 | 0.00% | 0.00% |
| 2020 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 28.37% | -100.21% |
US
|
|
| 12.36% | -100.09% |
FR
|
|
| 11.78% | -100.09% |
US
|
|
| 31.11% | -100.23% |
JP
|
|
| 10.21% | -100.08% |
CH
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Kestra Medical Technologies, Ltd.'s operating margin
What is Kestra Medical Technologies, Ltd.'s operating margin?
Kestra Medical Technologies, Ltd.'s operating margin is -134.48%, as of Nov 2026.
What was Kestra Medical Technologies, Ltd.'s operating margin in 2025?
In 2025, Kestra Medical Technologies, Ltd.'s operating margin was -177.85%, compared with -305.83% in 2024.
How has Kestra Medical Technologies, Ltd.'s operating margin changed since 2020?
From 2020 to 2025, Kestra Medical Technologies, Ltd.'s operating margin was highest in 2021 (0.00%) and lowest in 2023 (-1,054.01%).
How does Kestra Medical Technologies, Ltd.'s operating margin compare with similar companies?
Kestra Medical Technologies, Ltd.'s operating margin (-134.48%) is lower than that of all 5 similar companies listed above. The highest among them is HOYA Corporation, with 31.11%.